Integris Medtech IPO vs Sky Alloys and Power IPO

Comparison between Integris Medtech IPO and Sky Alloys and Power IPO.

IPO Details

Integris Medtech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sky Alloys and Power IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Integris Medtech IPO is up to ₹0.00 Cr whereas the issue size of the Sky Alloys and Power IPO is up to ₹0.00 Cr. The final issue price of Integris Medtech IPO is and of Sky Alloys and Power IPO is .

 Integris Medtech IPOSky Alloys and Power IPO
Face Value₹1 per share₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)
Discount (Retail)
Discount (Employee)
Market Lot Size
Fresh Issue Size0 shares1,60,84,000 shares
Fresh Issue Size (Amount)up to ₹925.00 Crup to ₹0.00 Cr
OFS Issue Size2,16,74,531 shares18,07,000 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total0 shares1,78,91,000 shares
Issue Size Total (Amount)up to ₹0.00 Crup to ₹0.00 Cr

IPO Timetable

Integris Medtech IPO opens on , while Sky Alloys and Power IPO opens on . The closing date of Integris Medtech IPO and Sky Alloys and Power IPO is , and , respectively.

Financials & KPIs

Integris Medtech IPO P/E ratio is , as compared to Sky Alloys and Power IPO P/E ratio of .

 Integris Medtech IPOSky Alloys and Power IPO
Financials

Company Financials (Restated Consolidated)

Integris Medtech Ltd.'s revenue increased by 24% and profit after tax (PAT) rose by 1547% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended30 Jun 202531 Mar 202531 Mar 202431 Mar 2023
Assets4,019.623,641.342,989.202,553.87
Total Income508.931,959.581,582.261,369.66
Profit After Tax267.5770.68-4.88-40.54
EBITDA78.73309.40190.45168.82
NET Worth3,889.992,752.522,681.022,629.52
Reserves and Surplus2,299.841,150.741,135.711,073.12
Total Borrowing793.421,729.46813.10556.54
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Sky Alloys & Power Ltd.'s revenue increased by 30% and profit after tax (PAT) rose by 18% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets524.08388.08285.75
Total Income821.09631.23555.47
Profit After Tax53.0544.9737.56
EBITDA110.3190.7978.63
NET Worth217.11164.14120.10
Reserves and Surplus170.5994.8850.84
Total Borrowing269.71178.58132.10
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)83.2472.33
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE5.35%27.83%
ROCE14.51%19.01%
Debt/Equity1.24
EPS₹6.52₹10.97
RoNW1.48%27.83%

Shares Offered

In the Integris Medtech IPO Retail Individual Investors (RII) are offered 0 shares while in Sky Alloys and Power IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Integris Medtech IPO and 0 shares in Sky Alloys and Power IPO.

 Integris Medtech IPOSky Alloys and Power IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation0 shares0 shares
QIB0 shares0 shares
NII0 shares0 shares
RII0 shares0 shares
Employee0 shares0 shares
Others
Total0 shares0 shares

Bids Received (Subscription)

Integris Medtech IPO subscribed in total, whereas Sky Alloys and Power IPO subscribed .

Compare with others

Compare:

Integris Medtech IPO Vs Sky Alloys and Power IPO